Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 2
2005 4
2006 4
2007 6
2008 4
2009 3
2010 4
2011 2
2012 4
2013 3
2014 1
2015 4
2016 9
2017 9
2018 4
2019 8
2020 10
2021 7
2022 5
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Heart rate turbulence in acute ischemic stroke.
Stengl H, Ganeshan R, von Rennenberg R, Hellwig S, Herm J, Krause T, Bauer A, Endres M, Georg Haeusler K, Scheitz JF, Nolte CH. Stengl H, et al. Among authors: krause t. Eur Stroke J. 2024 Mar;9(1):226-234. doi: 10.1177/23969873231211166. Epub 2023 Nov 6. Eur Stroke J. 2024. PMID: 37932964 Free PMC article.
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study.
Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Efken P, Mohl W, Hoffstadt M, Krause T, Schweitzer A, Schnoy E, Atreya R, Teich N, Trentmann L, Ehehalt R, Hartmann P, Schreiber S. Bokemeyer B, et al. Among authors: krause t. Inflamm Bowel Dis. 2024 May 2;30(5):746-756. doi: 10.1093/ibd/izad138. Inflamm Bowel Dis. 2024. PMID: 37523666
Enhanced diagnostic workup increases pathological findings in patients with acute ischaemic stroke: results of the prospective HEBRAS study.
Hellwig S, Krause T, Scheitz JF, Herm J, Grittner U, Jauert N, Fiebach JB, Kasner M, Doehner W, Endres M, Wachter R, Elgeti T, Nolte CH, Haeusler KG. Hellwig S, et al. Among authors: krause t. Stroke Vasc Neurol. 2024 Apr 30;9(2):145-152. doi: 10.1136/svn-2022-002179. Stroke Vasc Neurol. 2024. PMID: 37353342 Free article.
Real-world effectiveness of vedolizumab compared to anti-TNF agents in biologic-naïve patients with ulcerative colitis: A two-year propensity-score-adjusted analysis from the prospective, observational VEDOIBD -study.
Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Efken P, Mohl W, Krause T, Hoffstadt M, Ehehalt R, Trentmann L, Schweitzer A, Jessen P, Hartmann P, Schreiber S. Bokemeyer B, et al. Among authors: krause t. Aliment Pharmacol Ther. 2023 Aug;58(4):429-442. doi: 10.1111/apt.17616. Epub 2023 Jun 15. Aliment Pharmacol Ther. 2023. PMID: 37322825
Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn's Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study.
Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Mohl W, Teich N, Hoffstadt M, Schweitzer A, von der Ohe M, Gauss A, Atreya R, Krause T, Blumenstein I, Hartmann P, Schreiber S. Bokemeyer B, et al. Among authors: krause t. Inflamm Bowel Dis. 2023 Nov 2;29(11):1741-1750. doi: 10.1093/ibd/izac271. Inflamm Bowel Dis. 2023. PMID: 36633301
Rsn-2-mediated directed foam enrichment of β-lactamase.
Krause T, Keshavarzi B, Dressel J, Heitkam S, Ansorge-Schumacher MB. Krause T, et al. Biotechnol J. 2022 Dec;17(12):e2200271. doi: 10.1002/biot.202200271. Epub 2022 Aug 19. Biotechnol J. 2022. PMID: 35933602
89 results